Anticonvulsant activity of bioflavonoid gossypin
The anticonvulsant activity of gossypin was investigated by studying the effects on seizures induced by pentelentetrazole, strychnine and maximal electroshock convulsive methods in mice. Gossypin (10 and 20 mg/kg) significantly reduced the duration of convulsion in tonic seizure induced by pentelenetetrazole (95 mg/kg, intraperitoneally). Gossypin (20 mg/kg p.o) significantly reduced the tonic extensor convulsion induced by strychnine and maximum electroshock-induced convulsions. The data obtained suggest that gossypin have anticonvulsant property and may probably be affecting both GABA aminergic and glycine inhibitory mechanism.
Achliya GS, Wadodkar SG, Darle AK. Evaluation of CNS activity of Bramhi Ghrita. Indian J Pharmacol. 2005; 37: 33-36.
Babu BH, Jayaram HN, Nair MG, Ajay Kumar KB, Padikkala J. Free radical scavenging, antitumor and anti-carcinogenic activity of gossypin. J Exp Clin Cancer Res. 2003; 6: 2281-89.
De Sarro A, Cecchetti V, Fravolini V, Naccari F, Tabarrini O, De Sarro G. Effects of novel b-desfluroquinolones and classic quinolones on pentelenetetrazole-induced seizures in mice. Antimicrob Agents Chemother. 1999; 43: 1729-36.
Gale MK. GABA and epilepsy basic concepts from preclinical research. Epilepsia 1992; 33 Suppl: S3-12.
Gupta YK, Malhotra J. Adenosinergic system as an endogenous anticonvulsant mechanism. J Physiol Pharmacol. 1997; 41; 329-43.
Loscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 1988; 2; 145-81.
Mattson RH. Drug treatment of partial epilepsy. Adv Neurol. 1992; 57: 643-50.
Meldrum BS. GABA agonists as antiepileptic agents. Adv Biochem Psycopharmacol. 1981; 26: 207-17.
McNamara JO. Drugs effective in the therapy of the epilepsies. In: Goodman and Gillmans The pharmacological basis of therapeutics. Hardman, JG, Limbird LE (eds). 10th ed. New York, McGraw-Hill, 2001, pp 521-39.
Porter RJ, Meldrum BS. Antiseizure drugs. In: Basic and clinical pharmacology. Katzung BG (ed). New York, Lange Medical Books/McGraw-Hill, 2001, pp 403-17.
Salahdeen HM, Yemitan OK. Neuropharmacological effects of aqueous leaf extract of Bryophyllum pinnatum in mice. African J Bio Med Res. 2006; 9: 101-07.
Sayin U, Cengiz S, Altug T. Vigabatin as an anticonvulsant against penteletetrazole seizures. Pharmacol Res. 1993; 28: 325-31.
Vidyasagar J, Srinivas M, Nagulu M, Venkatasam A, Udyakiran B, Krishna DR. Protein binding study of gossypin by equilibrium dialysis. Curr Trends Biotech Phar. 2008; 2: 396-401.
Viola H, Wasowski C, Levidestein M, Wolfmane, Silveria R, Dajas F, Medina JH, Paladini AC. Apigenin, a componant of Marlicaria recutita flowers, is a central benzodiazepine receptors-legand with anxiolytic effects. Planta Med. 1995; 61: 213-16.
Westmoreland BF, Benarroch EE, Dube JR, Regan TJ, Sandok BA. Medical neurosciences. Mayo Foundation Rochester 1994, pp 307-12.
White HS. Clinical significance of animal seizure models and mechanism of action, studies of potential antiepileptic drugs. Epilepsia 1995; 38 Suppl: S9-17.
WHO. Epilepsy: Etiology, epidemiology and prognosis. www.who.int/entire/mediacentre/factsheets/fs165/en/-25k-16jan2006.
Wolfman C, Viola H, Paladini A, Dajas F, Media JH. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passifloara coerulea. Pharmacol Biochem Behav. 1994; 47: 1-4.
Yemitan OK, Adeymi OO. CNS depressant activity of Lecaniodisurs cupanioides. Fitoterpia 2005; 76: 412-18.
Yemitan OK, Salahdeen HM. Neurosedative and muscle relaxant activities of aqueous extract of Bryophyllum pinnatum. Fitoterpia 2005; 76: 187-93.
Copyright (c) 2009 Duraisami Rasilingam, Srinivasan Duraisamy, Ramaswamy Subramanian
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).